Skip to main content

GILD Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Gilead Sciences Inc. News

Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact

Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.

Pfizer Used AI to Design Paxlovid. Is Schrondinger Next?

Biotech may be one of the biggest beneficiaries of artificial intelligence and machine learning.

Cramer's Mad Money Recap 3/18: Nike, Nvidia, Adobe

Game plan for the week ahead with earnings from Nike, Adobe, KB Home and a keynote from Nvidia's CEO.

Cramer's Mad Money Recap 2/4: Take-Two Interactive, Disney, Twitter

Earnings from Take-Two Interactive, Disney and Twitter highlight Jim Cramer's game plan for next week.

Gilead Sciences Sues to Block Sellers of Counterfeit HIV Meds

Gilead Sciences uncovered a network that sold some $250 million of counterfeit versions of its HIV medications, a media report says.

Breaking News

Roe Decision Forces Disney, Netflix to Take a Political Stand

Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.

Stock Market Today-6/24: Dow Surges 800 Points As 'Relief Rally' Defies Global Growth Concerns

Stocks finished sharply higher Friday as investors rode a so-called 'relief rally' while re-setting other market prices for a near-term recession.

These Five Things Could Help (or Hurt) Internet Stocks

Bank of America analysts outline some of the biggest issues facing Amazon, Alphabet, Meta and other internet-related stocks.